GlaxoSmithKline (Switzerland)

Uncovering lung virome signatures of COPD severity and acute exacerbations in longitudinally sampled AERIS cohort

Chronic Obstructive Pulmonary Disease (COPD) is increasingly recognized as a complex disorder in which microbial communities may modulate disease progression and exacerbation risk. We investigated the contribution of the respiratory virome to disease severity and acute exacerbati...